These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4765459)

  • 1. [Effect of 6 per cent dextran 70 Polfa transfusions on blood clotting and hemostasis].
    Rudowski W; Kostrzewska E; Meissner AJ; Lopaciuk S; Uszyński L
    Pol Tyg Lek; 1973 Oct; 28(41):1581-3. PubMed ID: 4765459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Dextran-65 Polfa on the blood clotting system].
    Badowski A; Stanowski E; Pelasa J
    Wiad Lek; 1973 May; 26(10):889-94. PubMed ID: 4710728
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of dextran and gelatin infusion on the coagulation and fibrinolytic process in rabbits subjected to combined radiation injuries].
    Pantelić D; Ciko Z; Knezević O
    Zb Vojnomed Akad; 1976; (18):33-8. PubMed ID: 1074334
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of dextran on fibrinolysis inhibition activity in serum.
    Carlin G; Saldeen T
    Thromb Res; 1978 Jun; 12(6):1165-75. PubMed ID: 151346
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Polfa dextran-40 on blood clotting system in thrombelastographic and laboratory studies].
    Badowski A; Stanowski E; Daciewicz Z; Pelasa J
    Pol Przegl Chir; 1973 Apr; 45(4):445-52. PubMed ID: 4699770
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of dextran 40,000 on the dynamics of blood clotting in thromboelastographic studies].
    Sulek K
    Pol Tyg Lek; 1971 Apr; 26(14):497-9. PubMed ID: 5574220
    [No Abstract]   [Full Text] [Related]  

  • 7. Disordered blood coagulation in burned children receiving high molecular weight dextran.
    Thomas T; Morris A; Rose MS
    J Clin Pathol; 1972 Jun; 25(6):473-7. PubMed ID: 5043372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of rheopolyglucin on the biochemical indices of the coagulation and fibrinolysis systems in the early recovery period after clinical death].
    Molchanova LV; Novoderzhkina IS
    Probl Gematol Pereliv Krovi; 1978 Apr; 23(4):36-8. PubMed ID: 652753
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of drugs and parenteral solutions on vascular fibrinolytic activity.
    Johnston WE; Silver D
    Surgery; 1975 Aug; 78(2):202-10. PubMed ID: 1154264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dextran and dynamic coagulation].
    Raby C; Bertrand H
    Presse Med (1893); 1969 Nov; 77(49):1819-20. PubMed ID: 5365693
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran.
    Cunliffe WJ; Menon IS
    Br J Dermatol; 1969 Mar; 81(3):220-5. PubMed ID: 5775073
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of infusion of dextran 70 on fibrinolysis inhibition activity in human serum.
    Carlin G; Modig J; Saldeen T
    Acta Chir Scand; 1979; 145(3):129-31. PubMed ID: 494957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable studies of the behaviour of the plasmic coagulation, the fibrinolysis as well as the platelets under application of dextran or hydroxyethyl-starch (HES).
    Popov-Cenić S; Müller N; Kladetzky RG; Hack G; Lang U
    Bibl Anat; 1977; (16 Pt 2):322-5. PubMed ID: 75005
    [No Abstract]   [Full Text] [Related]  

  • 14. [The anticoagulant and fibrinolytic activity of dextran sulphate (MDS) (author's transl)].
    Matsuoka M; Jinbo C; Watanabe T; Nonura J; Sakuragawa N
    Rinsho Ketsueki; 1973 Aug; 14(8):882-90. PubMed ID: 4128641
    [No Abstract]   [Full Text] [Related]  

  • 15. [On blood coagulation following osmo-oncotherapy].
    Schmidt K; Reese L; Wolf P
    Anaesthesist; 1968 Jan; 17(1):13-7. PubMed ID: 5669457
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dextran on clotting time: steric exclusion accelerates fibrin monomer polymerisation.
    Rampling MW; Lane DA; Kakkar VV
    Thromb Res; 1976 Oct; 9(4):379-86. PubMed ID: 10639
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy.
    Palevsky PM; Burr R; Moreland L; Tokiwa Y; Greenberg A
    ASAIO J; 1995; 41(4):847-9. PubMed ID: 8589465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of dextran on coagulation and hemostasis phenomena].
    Bergentz SE
    Anesth Analg (Paris); 1976; 3(4):573-6. PubMed ID: 1015643
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of dextran infusion on the adhesiveness of human blood-platelets.
    Bennett PN; Dhall DP; McKenzie FN; Matheson NA
    Lancet; 1966 Nov; 2(7471):1001-3. PubMed ID: 4162658
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of high molecular dextran on coagulation and metastes.
    Agostino D
    Tumori; 1976; 62(3):245-54. PubMed ID: 1014121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.